Loading company…
Riskpilot
← Back to search
Sign in
Get full access
UTIGARD KONSULTING AS
AS
Active
Org 924926309
Ensjøsvingen 6B, 0661 Oslo
Manufacture of medical and dental instruments and supplies · NACE 3250
Est. 2020
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 96K
-64% vs 2024
EBITDA margin
-92.2%
+51% vs 2024
Equity ratio
3.4%
Financial strength
Net profit 2025
NOK -88K
+51% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 96K
-64%
EBITDA
NOK -88K
+51%
Net profit
NOK -88K
+51%
Total assets
NOK 23K
-94%
Equity
NOK 755
-99%
Employees
1
—
Company information
Legal name
UTIGARD KONSULTING AS
Org number
924926309
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
15. april 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Drive konsulentvirksomhet innen produktutvikling og produksjon av biocider, medisinsk utstyr og legemidler.
Contact
Address
Ensjøsvingen 6B, 0661 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of medical and dental instruments and supplies
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
0M
2023
0M
2024
0M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
1 422
253
267
96
Staff expenses
−0
−952
−322
−440
−179
EBITDA
0
418
−80
−182
−88
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
0
418
−80
−182
−88
Net financials
0
0
−1
0
0
Profit before tax
0
418
−81
−182
−88
Tax
−0
91
−0
−0
−0
Net profit
0
327
−81
−182
−88
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
24
742
313
356
23
Equity
24
351
271
89
1
Long-term debt
0
0
0
0
0
Short-term debt
0
391
42
267
22
Total debt
0
391
42
267
22
Financial ratios
5-year trend
EBITDA margin
-92.2%
This company
15.8%
Market median
-684% vs market
2021
2025
Equity ratio
3.4%
This company
38.2%
Market median
-91% vs market
2021
2025
Return on equity
-11688.1%
This company
18.4%
Market median
-63622% vs market
2021
2025
Net profit margin
-92.1%
This company
8.1%
Market median
-1237% vs market
2021
2025
Asset turnover
4.26×
This company
1.12×
Market median
+280% vs market
2021
2025
Debt / equity
28.81×
This company
0.62×
Market median
-4547% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
GU
Geir Utigard
Chairman
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of UTIGARD KONSULTING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Geir Utigard
Chairman
0 companies